Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia

Ejemplares similares

• Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
  por: Zhang LT, et al.
  Publicado: (2015)
• Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia and Overactive Bladder (Silodosing) Study Protocol (Spirit Compliant)
  por: Magdalena Hagovska, et al.
  Publicado: (2021)
• An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin
  por: Yang PS, et al.
  Publicado: (2018)
• Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial
  por: Amr Fawzi, et al.
  Publicado: (2017)
• The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia
  por: Shao IH, et al.
  Publicado: (2013)